- This event has passed.
Advanced Therapies Integrates 2021
07/10/2021 @ 8:30 am - 5:00 pm
Enabling Strategic Debate and Collaboration Across the Advanced Therapies and Medicinal Products (ATMP) Industry.
Innovation in pharmaceutical discovery and development is taking place at an astonishing pace. The genomics revolution and other advances have led to the emergence of highly effective, but extremely complex therapeutics, with cell and gene therapies, regenerative medicines and tissue therapies now transforming the prospects of patients and healthcare providers around the globe.
However there remain many strategic challenges to the effective development, deployment and utilisation of these ground-breaking medical technologies. Advanced Therapies Integrates will constitute a new forum, dedicated to bringing together the industry leaders to help drive and deliver the full potential ATMPs.
It will uniquely engage across the widest possible network: from pharma innovators, regulators, supply chain partners, equipment & technology providers, academia, industry associations, together with a wide array of government funding bodies and government supported pharma-focused initiatives.
Specific themes and objectives will cover deployment of the key innovations and debating challenges facing the industry including the regulatory and commercial barriers to effectively deploy such broad transformational changes.
Advanced Therapies Integrates will become the leading UK event that facilitates the translation of cutting-edge research and disruptive innovation into the wide-spread adoption of Advanced Therapies, delivering improved patient outcomes and a revolution in healthcare economics.
The RSA Group is proud to be participating in two sessions:
Britain’s Talent for technology, 10:35-11:25
Do we have the right skills and capabilities in place to identify and develop the next generation of ATMPs?
FACILITATED BY
JAMES STRACHAN | Editor | The Cell + Gene Curator
PANELLISTS INCLUDE
NICK STEPHENS | Executive Chairman | The RSA Group
CHRIS NOWERS | Chief Executive Officer | ONK Therapeutics
CHARLOTTE CASEBOURNE | Chief Executive Officer and Co-founder | Theolytics
STEPHEN WARD | Chief Manufacturing Officer| Cell and Gene Therapy Catapult
COLIN MACKAY | Founder and CEO | Symbiosis Pharmaceutical Services Ltd
Productive People, 11:55-12:45
As manufacturing technologies continue to emerge, we must have the skills to deliver the science at scale. How can we ensure that talent tracks with emergent manufacturing trends?
FACILITATED BY
JAMES GREGORY | Managing Partner | The RSA Group
PANELLISTS INCLUDE
JANE KENNEDY | Chief Business Officer | Discovery Park
LUCY FOLEY | Director of Biologics | CPI
KEVIN BRUCE | Chief Operating Officer | Roslin Cell Therapies Ltd